511 – 520 of 663
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
(
- Contribution to journal › Article
-
Mark
FLT3 and KIT in acute myeloid leukemia. Translational studies on oncogenic signaling from receptor tyrosine kinases. : Translational studies on oncogenic signaling from receptor tyrosine kinases
2016)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Studies on renal progenitor cells and kidney cancer
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Putative role of SUMOylation in controlling the activity of deubiquitinating enzymes in cancer.
(
- Contribution to journal › Scientific review
-
Mark
Expression of GADS enhances FLT3-induced mitogenic signaling.
(
- Contribution to journal › Article
-
Mark
CYLD and SUMO in neuroblastoma therapy
(
- Contribution to journal › Article
-
Mark
Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer
(
- Contribution to journal › Article
-
Mark
Src-Like Adapter Protein (SLAP)
2016) p.1-4(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Src-Like Adapter Protein 2 (SLAP2)
(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
The putative tumor suppressor gene EphA7 is a novel BMI-1 target
(
- Contribution to journal › Article